FdaApplication
ANDA 207271
Identifiers
- fda_app_no: ANDA207271
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-11-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MESALAMINE | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE;ORAL |
1 product